Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

NCT00321932 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes
Osteoporosis
Ovarian Cancer

Interventions

DIETARY_SUPPLEMENT: calcium
DIETARY_SUPPLEMENT: cholecalciferol
DRUG: zoledronic acid

Sponsor

University of Minnesota